Talking Rheumatology Research cover art

Talking Rheumatology Research

Talking Rheumatology Research

Written by: British Society for Rheumatology
Listen for free

About this listen

Discover the latest research from Rheumatology, Rheumatology Advances in Practice, and beyond.© 2025 Talking Rheumatology Research Hygiene & Healthy Living Physical Illness & Disease
Episodes
  • Ep 51. Infliximab vs interferon-α in the treatment of Behçet’s syndrome: clinical data from the BIO-BEHÇET’S randomized controlled trial
    Aug 13 2025

    In this episode, recorded live at BSR25, Professor Robert J Moots joins Professor Ernest Choy to discuss their article reporting on a randomized, controlled, head-to-head clinical trial comparing the two most frequently used biologics in active refractory Behçet’s.

    Listen now to hear the findings and what this means for future clinical practice!

    Further reading: You can read this article [https://doi.org/10.1093/rheumatology/keae585] in Rheumatology.

    Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn.

    Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

    Show More Show Less
    8 mins
  • Ep 50. Modifiable risk factors and therapeutic targets in polymyalgia rheumatica
    Jun 12 2025

    How can we identify modifiable risk factors and new therapeutic targets in polymyalgia rheumatica?

    In this episode, recorded live at BSR25, Prof Ernest Choy and Dr Steven Zhao discuss Steven's genome-wide meta-analysis and Mendelian randomisation study. They cover the key findings, which include some novel loci and potential therapeutic targets for PMR, as well as the hallmarks of a good Mendelian randomisation study.

    Further reading:

    1. Read Steven's full study in Rheumatology


    Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn.

    Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

    Show More Show Less
    9 mins
  • Ep 49. Improving time to diagnosis in axial spondyloarthritis
    May 8 2025

    How can we improve time from symptom onset to axSpA diagnosis?

    In this episode, Dr Fabian Proft talks to Dr Antoni Chan about his fantastic work to reduce time to diagnosis in axial spondyloarthritis (axSpA) using an integrated referral and education system. They discuss the importance of a multi-pronged approach to education, as well as how clinicians might start improving time to axSpA diagnosis in their own settings.

    Further reading:

    1. Read Antoni's full article in Rheumatology Advances in Practice
    2. Find out more about the Act on Axial SpA campaign
    3. Access the axSpA symptom checker


    Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn.

    Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

    Show More Show Less
    11 mins
No reviews yet